Provided by Tiger Trade Technology Pte. Ltd.

Cogent Biosciences, Inc.

39.34
-0.2100-0.53%
Volume:2.12M
Turnover:83.21M
Market Cap:6.04B
PE:-15.94
High:39.94
Open:39.00
Low:38.31
Close:39.55
52wk High:43.73
52wk Low:3.72
Shares:153.51M
Float Shares:143.00M
Volume Ratio:0.65
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4685
EPS(LYR):-2.4616
ROE:-95.40%
ROA:-47.47%
PB:31.04
PE(LYR):-15.98

Loading ...

BUZZ-Cogent Biosciences steady after upsized $500 mln capital raise

Reuters
·
Nov 12

Cogent Biosciences Prices $475 Million in Combined Equity, Convertible Notes Offerings

MT Newswires Live
·
Nov 12

BRIEF-Cogent Biosciences Announces Pricing Of Concurrent Public Offerings Of Common Stock And 1.625% Convertible Senior Notes Due 2031

Reuters
·
Nov 12

Cogent Biosciences Inc - Prices Public Offering of 9,677,420 Shares at $31.00 Each

THOMSON REUTERS
·
Nov 12

BUZZ-Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles

Reuters
·
Nov 11

Cogent announces $200M convertible senior notes, $200M common stock offerings

TIPRANKS
·
Nov 11

Cogent Biosciences Inc - to Use Proceeds to Repay $50 Mln in Loans

THOMSON REUTERS
·
Nov 11

Press Release: Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock

Dow Jones
·
Nov 11

Sector Update: Health Care Stocks Advance Monday Afternoon

MT Newswires Live
·
Nov 11

Top Midday Gainers

MT Newswires Live
·
Nov 11

Cogent Biosciences rises 135.0%

TIPRANKS
·
Nov 11

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results

Benzinga
·
Nov 11

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries

Reuters
·
Nov 11

Cogent Biosciences Inc : Wedbush Raises to Outperform From Neutral; Raises Target Price to $38 From $13

THOMSON REUTERS
·
Nov 10

BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks

Reuters
·
Nov 10

Cogent Biosciences Shares Double On Tumor Drug Positive Trial Results

Dow Jones
·
Nov 10

Cogent Biosciences Shares up 121% Premarket After Co's Combo Drug Slows Cancer Progression in Late-Stage Trial

THOMSON REUTERS
·
Nov 10

BUZZ-Cogent Biosciences soars as combo drug slows cancer progression in trial

Reuters
·
Nov 10

Stock Track | Cogent Biosciences Skyrockets 103% Pre-market on Positive Phase 3 Trial Results for GIST Treatment

Stock Track
·
Nov 10

Cogent Biosciences reports data from Phase 3 PEAK trial of bezuclastinib

TIPRANKS
·
Nov 10